IMMUNOGLOBULIN E 04827031190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2015-11-18 for IMMUNOGLOBULIN E 04827031190 manufactured by Roche Diagnostics.

Event Text Entries

[31571780] This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[31571781] The customer complained of erroneous results for 1 patient tested for immunoglobulin e (ige ii). It is not known if any erroneous results were reported outside of the laboratory. The initial ige ii result from a serum sample was 1555 iu/ml. The sample was repeated on (b)(6) 2015 and the result was 1487 iu/ml. The sample was diluted x2 and the result was >5000 iu/ml. The sample was diluted x10 and the result was 6906 iu/ml. On (b)(6) 2015, a new sample was obtained and the result from a serum sample was 1236 iu/ml. This sample was diluted x2 and the result was > 4454 iu/ml. The sample was diluted x10 and the result was 9154 iu/ml. On (b)(6) 2015, a new sample was obtained and the result from a serum sample was 1115 iu/ml. The sample was diluted x100 and the result was 13402 iu/ml. The results from a plasma sample were 1192 iu/ml. The sample was diluted x100 and the result was 13998 iu/ml. It is not known if the patient was adversely affected. No adverse event was reported. The e602 analyzer serial number was not provided. The sample from (b)(6) 2015 was sent in for investigation. The sample was sent to an external laboratory and the fluorescent enzyme immunoassay (feia) ige result was 2803 iu/ml. On (b)(6) 2015, a sample from a different patient was tested for ige ii and the result was approximately 2500 iu/ml. This patient's sample was sent to the investigation unit as a reference value. No further information is available about this patient. The sample was sent to an external laboratory and the feia ige result diluted x10 was 7004 iu/ml.
Patient Sequence No: 1, Text Type: D, B5


[33719854] The customer provided the patient samples in question and the reference sample for investigation. It was determined the patient samples contain anti-ige antibodies that aggregate with the ige molecules. This interference is addressed in product labeling.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2015-04579
MDR Report Key5233423
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2015-11-18
Date of Report2015-12-16
Date of Event2015-10-13
Date Mfgr Received2015-11-05
Date Added to Maude2015-11-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameIMMUNOGLOBULIN E
Generic NameRADIOIMMUNOASSAY, IMMUNOGLOBULINS (D, E)
Product CodeJHR
Date Received2015-11-18
Model NumberNA
Catalog Number04827031190
Lot Number181429
ID NumberNA
Device Expiration Date2016-06-29
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2015-11-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.